Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
AFRICA – Gavi, the Vaccines Alliance has appointed Amref Health Africa as the new host of its Civil Society Organization (CSO) platform effective from 1 January 2022 for a period…
Read More
AFRICA – More than 1 million children have been vaccinated against malaria in a pilot programme for the world’s first malaria vaccine in Ghana, Kenya and Malawi in coordination with…
Read More
SWITZERLAND – The global vaccine alliance Gavi has secured US$4.8 billion in funding pledges for the vaccine-sharing scheme COVAX, falling just short of its target. The secured fund falls short…
Read More
MALAWI – Malawi has received about 2 million doses of Oral Cholera Vaccine (OCV) from the Global Emergency Stockpile funded by Gavi, the Vaccine Alliance in an effort to contain…
Read More
SOMALIA – Somalia’s Federal Government and members of the Global Polio Eradication Initiative (GPEI) have introduced extensive measures to curb the ongoing poliovirus type 2 (cVDPV2) outbreak in the country.…
Read More
AFRCA – The Board of Gavi, the Vaccine Alliance has approved an investment to support the malaria vaccine introduction, procurement and delivery for Gavi-eligible countries in sub-Saharan Africa in 2022-2025.…
Read More
ETHIOPIA – The World Health Organization (WHO), the African Union, Unicef, GAVI, the vaccine alliance, and the Africa Centre for Disease Control and Prevention (CDC) have issued a joint statement…
Read More
NIGERIA – The National Primary Health Care and Development Agency (NPHCDA), World Health Organization (WHO), UNICEF, Gavi, the global vaccine alliance, and partners have entered into a treaty that will…
Read More
AFRICA – Gavi, the Vaccine Alliance, together with WHO, UNICEF, CDC, the Institut Pasteur Dakar, Centre Pasteur Cameroon, and the Uganda Virus Research Institute has funded implementation of the Eliminate…
Read More
AFRICA – Covax has slashed its forecasts for Covid-19 vaccine deliveries to the developing world by about 25 per cent this year after India’s export ban, manufacturing problems and delays…
Read More